Literature DB >> 18368614

Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence.

Frances J Kay-Lambkin1.   

Abstract

ISSUES: The dramatic increase in methamphetamine use has led to the urgent need for high-quality, effective treatments and management strategies for methamphetamine use problems to be developed and disseminated. Although some evidence exists for the use of psychological, pharmacological and other approaches to treatment for problematic methamphetamine use, other evidence suggests that many methamphetamine users do not access these treatment options due to a range of individual and service-level barriers. APPROACH: A review of available research literature was undertaken to identify treatment strategies for methamphetamine users, which overcome the problems associated with treatment access for this important target group and involve technological and other innovative approaches. KEY
FINDINGS: Several approaches to addressing problematic methamphetamine use have been suggested, including assertive engagement strategies, flexibility in the provision of treatment and retention strategies and use of a multi-focused intervention package, such as stepped care, perhaps including new technologies as alternatives or supplements to face-to-face-delivered treatments. No research currently exists to examine the possible benefit of these strategies for people with methamphetamine use problems. IMPLICATIONS: The use of stepped-care intervention packages has the potential to address many of the current challenges faced by both clinicians and clients in treating methamphetamine use problems.
CONCLUSIONS: Although promising, these approaches require further attention and research effort, particularly among the specific group of methamphetamine users.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368614     DOI: 10.1080/09595230801914768

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  7 in total

Review 1.  Computer-based interventions for drug use disorders: a systematic review.

Authors:  Brent A Moore; Tera Fazzino; Brian Garnet; Christopher J Cutter; Declan T Barry
Journal:  J Subst Abuse Treat       Date:  2010-12-24

2.  Assessment of function and clinical utility of alcohol and other drug web sites: an observational, qualitative study.

Authors:  Frances J Kay-Lambkin; Angela White; Amanda L Baker; David J Kavanagh; Britt Klein; Judith Proudfoot; Judy Drennan; Jason Connor; Ross M Young
Journal:  BMC Public Health       Date:  2011-05-05       Impact factor: 3.295

3.  Effects of Personalized Feedback Interventions on Drug-Related Reoffending: a Pilot Study.

Authors:  Kenji Yokotani; Katsuhiro Tamura
Journal:  Prev Sci       Date:  2015-11

Review 4.  The methamphetamine problem in the United States.

Authors:  Rachel Gonzales; Larissa Mooney; Richard A Rawson
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

5.  Breakingtheice: a protocol for a randomised controlled trial of an internet-based intervention addressing amphetamine-type stimulant use.

Authors:  Robert J Tait; Rebecca McKetin; Frances Kay-Lambkin; Kylie Bennett; Ada Tam; Anthony Bennett; Jenny Geddes; Adam Garrick; Helen Christensen; Kathleen M Griffiths
Journal:  BMC Psychiatry       Date:  2012-06-25       Impact factor: 3.630

6.  A Web-Based Intervention for Users of Amphetamine-Type Stimulants: 3-Month Outcomes of a Randomized Controlled Trial.

Authors:  Robert J Tait; Rebecca McKetin; Frances Kay-Lambkin; Bradley Carron-Arthur; Anthony Bennett; Kylie Bennett; Helen Christensen; Kathleen M Griffiths
Journal:  JMIR Ment Health       Date:  2014-09-11

7.  The Molecular-Container Calabadion-2 Prevents Methamphetamine-Induced Reinstatement in Rats: A Potential Approach to Relapse Prevention?

Authors:  Michael Z Leonard; Paul Rostin; Kevin P Hill; Stephanie D Grabitz; Matthias Eikermann; Klaus A Miczek
Journal:  Int J Neuropsychopharmacol       Date:  2020-06-24       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.